Research Site
Osaka, Japan
NCT Number: NCT00687232
The purpose is to investigate safety and tolerability of single and multiple ascending inhaled doses of AZD4818 in healthy Japanese male volunteers.
Looking for future studies?
Notify Me20 year–45 year
Male
Interventional
Phase 1
Osaka, Japan
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Dry powder, inhalation, b.i.d, 10 + 1/2 days or 20 + 1/2 days
Time frame: During the study
Time frame: During the study
Time frame: During the study
AstraZeneca
Industry
A Randomised, Placebo-controlled Single-blind, Single-centre Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Inhaled Doses of AZD4818 in Healthy Japanese Male Volunteers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03246581
Healthy, Pathologic Processes
Loughborough, United Kingdom
View Trial DetailsNCT06662019
Healthy, Pathologic Processes
Perth, Western Australia, Australia
View Trial DetailsNCT02627625
Healthy, Pathologic Processes
Ruddington, Nottingham, United Kingdom
View Trial DetailsNCT02676297
Healthy, Pathologic Processes
Ruddington, Nottingham, United Kingdom
View Trial Details